Shares of I-Mab (IMAB) is currently trading at $79.17, up $7.47 or 10.43%, with trading volume of 208K versus an average volume of 587K shares. The stock has been trading between $32.64 and $85.40 for the past one year.

Create Account

Dark

chart

exchange

RTTNews | Sep 7, 2021 10:02AM EDT

10:01 Tuesday, September 7, 2021 (RTTNews.com) - Shares of I-Mab (IMAB) is currently trading at $79.17, up $7.47 or 10.43%, with trading volume of 208K versus an average volume of 587K shares. The stock has been trading between $32.64 and $85.40 for the past one year.

This clinical stage biopharmaceutical company I-Mab, on September 2, 2021, said it has been added to FTSE Global Equity Index Series, following FTSE's most recent semi-annual review. These inclusions will become effective after the market close on Friday, September 17, 2021.

Last month, I-Mab announced positive interim data from its U.S. phase 2/3 study of plonmarlimab for the treatment of cytokine release syndrome or CRS in patients with severe COVID-19.

Read the original article on RTTNews ( https://www.rttnews.com/3223757/i-mab-stock-gains-10.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved